Gentian Diagnostics ASA (OSL:GENT)
38.90
-0.60 (-1.52%)
At close: Mar 2, 2026
-21.26% (1Y)
| Market Cap | 599.93M |
| Revenue (ttm) | 176.50M |
| Net Income (ttm) | 13.26M |
| Shares Out | 15.42M |
| EPS (ttm) | 0.86 |
| PE Ratio | 45.26 |
| Forward PE | 14.85 |
| Dividend | 0.60 (1.52%) |
| Ex-Dividend Date | May 6, 2026 |
| Volume | 32,184 |
| Average Volume | 43,448 |
| Open | 40.00 |
| Previous Close | 39.50 |
| Day's Range | 38.10 - 40.00 |
| 52-Week Range | 36.10 - 65.80 |
| Beta | 0.44 |
| RSI | 27.78 |
| Earnings Date | Feb 11, 2026 |